Standard

Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy. / Позмогова, Татьяна Николаевна; Vegner, Margarita V; Vorotinkov, Yuri A. и др.

в: Biomaterials Science, 16.09.2025.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Позмогова, ТН, Vegner, MV, Vorotinkov, YA, Короткова, СВ, Громова, МА, Цыганкова, АР, Гусельникова, ТЯ, Vavilov, GD, Kuratieva, NV, Стась, ДВ, Шестопалова, ЛВ, Khripko, O, Shestopalov, AM & Shestopalov, MA 2025, 'Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy', Biomaterials Science. https://doi.org/10.1039/D5BM00909J

APA

Позмогова, Т. Н., Vegner, M. V., Vorotinkov, Y. A., Короткова, С. В., Громова, М. А., Цыганкова, А. Р., Гусельникова, Т. Я., Vavilov, G. D., Kuratieva, N. V., Стась, Д. В., Шестопалова, Л. В., Khripko, O., Shestopalov, A. M., & Shestopalov, M. A. (2025). Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy. Biomaterials Science. https://doi.org/10.1039/D5BM00909J

Vancouver

Позмогова ТН, Vegner MV, Vorotinkov YA, Короткова СВ, Громова МА, Цыганкова АР и др. Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy. Biomaterials Science. 2025 сент. 16. doi: 10.1039/D5BM00909J

Author

BibTeX

@article{63cc25293ee54363b7ea8b9118c90abd,
title = "Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy",
abstract = "Cancer treatment faces significant challenges due to tumor heterogeneity, drug resistance, and the limited efficacy of single-agent therapies, driving the search for novel therapeutic approaches. The water-soluble molybdenum cluster complex Na5Cs3[{Mo6I8}(S2O3)6]·3H2O, developed in this study, represents a unique compound that combines a strong chemotherapeutic effect, achieved through the controlled release of sulfur-containing gas-signaling molecules (H2S and SO2) during hydrolysis, with a radiodynamic effect, enabled by the ability of the cluster to generate singlet oxygen (1O2) under X-rays. The results of in vitro experiments confirmed significant cytostatic effects on cancer cells, while in vivo studies using Nu/J mice xenografted with HeLa tumors showed substantial tumor growth inhibition when the cluster was administered subcutaneously in combination with X-ray irradiation. Overall, the dual functionality of the cluster, along with the slow release and prolonged retention of the complex in tumor tissues, makes it a highly promising candidate for advanced cancer treatment strategies, particularly when integrated with conventional radiotherapy.",
author = "Позмогова, {Татьяна Николаевна} and Vegner, {Margarita V} and Vorotinkov, {Yuri A.} and Короткова, {Софья Владимировна} and Громова, {Мария Анатольевна} and Цыганкова, {Альфия Рафаэльевна} and Гусельникова, {Татьяна Яковлевна} and Vavilov, {Georgy D.} and Kuratieva, {Nataliya V.} and Стась, {Дмитрий Владимирович} and Шестопалова, {Лидия Владимировна} and Olga Khripko and Shestopalov, {Aleksander M} and Shestopalov, {Michael A.}",
note = "Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy / T. N. Pozmogova, M. V. Vegner, Y. A. Vorotinkov, S. V. Korotkova, M. A. Gromova, A. R. Tsygankova, T. Y. Guselnikova, G. D. Vavilov, N. V. Kuratieva, D. V. Stass, L. V. Shestopalova, О. P. Khripko, A. M. Shestopalov, M. A. Shestopalov // Biomaterials Science. - 2025. DOI: 10.1039/D5BM00909J ",
year = "2025",
month = sep,
day = "16",
doi = "10.1039/D5BM00909J",
language = "English",
journal = "Biomaterials Science",
issn = "2047-4830",
publisher = "Royal Society of Chemistry",

}

RIS

TY - JOUR

T1 - Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy

AU - Позмогова, Татьяна Николаевна

AU - Vegner, Margarita V

AU - Vorotinkov, Yuri A.

AU - Короткова, Софья Владимировна

AU - Громова, Мария Анатольевна

AU - Цыганкова, Альфия Рафаэльевна

AU - Гусельникова, Татьяна Яковлевна

AU - Vavilov, Georgy D.

AU - Kuratieva, Nataliya V.

AU - Стась, Дмитрий Владимирович

AU - Шестопалова, Лидия Владимировна

AU - Khripko, Olga

AU - Shestopalov, Aleksander M

AU - Shestopalov, Michael A.

N1 - Octahedral iodide Mo6 cluster complex bearing thiosulfate ligands: a dual chemotherapeutic and radiodynamic agent for advanced cancer therapy / T. N. Pozmogova, M. V. Vegner, Y. A. Vorotinkov, S. V. Korotkova, M. A. Gromova, A. R. Tsygankova, T. Y. Guselnikova, G. D. Vavilov, N. V. Kuratieva, D. V. Stass, L. V. Shestopalova, О. P. Khripko, A. M. Shestopalov, M. A. Shestopalov // Biomaterials Science. - 2025. DOI: 10.1039/D5BM00909J

PY - 2025/9/16

Y1 - 2025/9/16

N2 - Cancer treatment faces significant challenges due to tumor heterogeneity, drug resistance, and the limited efficacy of single-agent therapies, driving the search for novel therapeutic approaches. The water-soluble molybdenum cluster complex Na5Cs3[{Mo6I8}(S2O3)6]·3H2O, developed in this study, represents a unique compound that combines a strong chemotherapeutic effect, achieved through the controlled release of sulfur-containing gas-signaling molecules (H2S and SO2) during hydrolysis, with a radiodynamic effect, enabled by the ability of the cluster to generate singlet oxygen (1O2) under X-rays. The results of in vitro experiments confirmed significant cytostatic effects on cancer cells, while in vivo studies using Nu/J mice xenografted with HeLa tumors showed substantial tumor growth inhibition when the cluster was administered subcutaneously in combination with X-ray irradiation. Overall, the dual functionality of the cluster, along with the slow release and prolonged retention of the complex in tumor tissues, makes it a highly promising candidate for advanced cancer treatment strategies, particularly when integrated with conventional radiotherapy.

AB - Cancer treatment faces significant challenges due to tumor heterogeneity, drug resistance, and the limited efficacy of single-agent therapies, driving the search for novel therapeutic approaches. The water-soluble molybdenum cluster complex Na5Cs3[{Mo6I8}(S2O3)6]·3H2O, developed in this study, represents a unique compound that combines a strong chemotherapeutic effect, achieved through the controlled release of sulfur-containing gas-signaling molecules (H2S and SO2) during hydrolysis, with a radiodynamic effect, enabled by the ability of the cluster to generate singlet oxygen (1O2) under X-rays. The results of in vitro experiments confirmed significant cytostatic effects on cancer cells, while in vivo studies using Nu/J mice xenografted with HeLa tumors showed substantial tumor growth inhibition when the cluster was administered subcutaneously in combination with X-ray irradiation. Overall, the dual functionality of the cluster, along with the slow release and prolonged retention of the complex in tumor tissues, makes it a highly promising candidate for advanced cancer treatment strategies, particularly when integrated with conventional radiotherapy.

UR - https://pubs.rsc.org/en/content/articlelanding/2025/bm/d5bm00909j#!divAbstract

U2 - 10.1039/D5BM00909J

DO - 10.1039/D5BM00909J

M3 - Article

JO - Biomaterials Science

JF - Biomaterials Science

SN - 2047-4830

ER -

ID: 70070366